PATENT CLAIM ANALYSIS

Application Number: 16025487
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "495000"]

Abstract:
Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.

Claim (Index 117):
The formulation of  claim 109 , wherein the one or more methacrylic acid-methyl methacrylate co-polymers comprise from about 20% to about 50% by weight of the controlled release coating.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 95.0
- Lexical Diversity: 1.71429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15655924', '14295098', '12264709', '15385447', '12773599']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756876814462061
- 35 USC 102 Novelty (BERT): 0.5341751778000984
- Combined Prediction Score: 0.7346066507958647
- Mean Citation Score: 309.10608600000006
- Max Citation Score: 370.71924
- Similarity Product: 260.63805711612224

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test